Literature DB >> 11385709

Frequency of recent retrotransposition events in the human factor IX gene.

X Li1, W A Scaringe, K A Hill, S Roberts, A Mengos, D Careri, M T Pinto, C K Kasper, S S Sommer.   

Abstract

Two germline retrotransposition mutations of recent origin were observed in 727 independent mutations (0.28%) in the human factor IX gene (F9) of patients with hemophilia B: 1) a 279 bp insertion in exon H originating from an Alu family of short interspersed elements not previously known to be active and, 2) a 463 bp insertion in exon E of a LINE1 element originating in the maternal grandmother. If the rates of recent germline mutation in F9 are typical of the genome, a retrotransposition event is estimated to occur somewhere in the genome of about one in every 17 children born. Analysis of other estimates for retrotransposition frequency and overall mutation rates suggests that the actual rate of retrotransposition is likely to be in the range of one in every 2.4 to 28 live births. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385709     DOI: 10.1002/humu.1134

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  32 in total

1.  Hot L1s account for the bulk of retrotransposition in the human population.

Authors:  Brook Brouha; Joshua Schustak; Richard M Badge; Sheila Lutz-Prigge; Alexander H Farley; John V Moran; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 2.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

3.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Authors:  Hal P Bogerd; Heather L Wiegand; Amy E Hulme; José L Garcia-Perez; K Sue O'Shea; John V Moran; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-25       Impact factor: 11.205

4.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

Review 5.  Nuclear function of Alus.

Authors:  Chen Wang; Sui Huang
Journal:  Nucleus       Date:  2014-02-04       Impact factor: 4.197

Review 6.  Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis.

Authors:  Mark C Wilkes; Claire E Repellin; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2017-07-25       Impact factor: 4.797

7.  HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene.

Authors:  P A Apoil; E Kuhlein; A Robert; H Rubie; A Blancher
Journal:  Immunogenetics       Date:  2006-12-05       Impact factor: 2.846

Review 8.  LINE-1 elements in structural variation and disease.

Authors:  Christine R Beck; José Luis Garcia-Perez; Richard M Badge; John V Moran
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

9.  Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A.

Authors:  Arupa Ganguly; Tanya Dunbar; Peiqin Chen; Lynn Godmilow; Tapan Ganguly
Journal:  Hum Genet       Date:  2003-07-12       Impact factor: 4.132

10.  Evidence consistent with human L1 retrotransposition in maternal meiosis I.

Authors:  Brook Brouha; Christof Meischl; Eric Ostertag; Martin de Boer; Yue Zhang; Herman Neijens; Dirk Roos; Haig H Kazazian
Journal:  Am J Hum Genet       Date:  2002-07-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.